Natco Pharma consolidated net profit declines 28.09% in the June 2025 quarter

Sales decline 2.47% to Rs 1328.90 crore

Net profit of Natco Pharma declined 28.09% to Rs 480.70 crore in the quarter ended June 2025 as against Rs 668.50 crore during the previous quarter ended June 2024. Sales declined 2.47% to Rs 1328.90 crore in the quarter ended June 2025 as against Rs 1362.60 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1328.901362.60 -2 OPM %42.9759.06 -PBDT629.50847.70 -26 PBT571.90803.60 -29 NP480.70668.50 -28

Powered by Capital Market - Live News